HomeCRDL • NASDAQ
Cardiol Therapeutics Inc
add
$0.99
0.22%
After Hours:(2.36%)-0.023
$0.97
Closed: Mar 27, 6:26:18 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 14.14M | 84.70% |
Net income | -12.73M | -114.64% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -14.10M | -85.78% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.89M | -60.82% |
Total assets | 17.52M | -59.31% |
Total liabilities | 7.09M | -13.37% |
Total equity | 10.43M | — |
Shares outstanding | 81.60M | — |
Price to book | 6.64 | — |
Return on assets | -161.30% | — |
Return on capital | -270.65% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -12.73M | -114.64% |
Cash from operations | -7.77M | -127.53% |
Cash from investing | -7.87K | -41.13% |
Cash from financing | -4.62K | 66.66% |
Net change in cash | -8.14M | -84.82% |
Free cash flow | -3.77M | -16.05% |
Previous close
$1.00
Day range
$0.96 - $1.02
Year range
$0.96 - $3.12
Market cap
119.78M CAD
Avg Volume
257.02K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
About
CEO
Founded
2017
Headquarters
Website
Employees
17
